Voyager shareholders approve Veraxa Biotech merger despite heavy redemptions
Voyager Acquisition (NASDAQ:VACH) moved one step closer to finalizing its merger with Veraxa Biotech following an extraordinary general meeting on March 12, 2026.
Todas as matérias desta seção, das mais recentes às mais antigas — página 255 de 371.
Voyager Acquisition (NASDAQ:VACH) moved one step closer to finalizing its merger with Veraxa Biotech following an extraordinary general meeting on March 12, 2026.
Emerald Holding (NYSE:EEX) reported a significant expansion of its top-line results for fiscal year 2025, fueled by the aggressive integration of new event brands and a steady recovery in organic attendance across its core trade show portfolio.
Century Casinos (NASDAQ:CNTY) reported a stark contrast between its operational efficiency and its bottom-line results for the fiscal year ended Dec. 31, 2025.
Adobe (NASDAQ:ADBE) shares plummeted on Friday, wiping out billions in market value after the creative software giant announced that Shantanu Narayen will step down as Chief Executive Officer.
Innovative Industrial Properties (NYSE:IIPR) signaled continued confidence in its cash flow profile on Friday, declaring a first-quarter 2026 dividend that keeps its annualized payout among the highest in the specialized real estate sector.
RLX Technology (NYSE:RLX) delivered a robust financial performance for fiscal year 2025, demonstrating a successful pivot toward international markets as the e-vapor leader navigates a shifting regulatory landscape in its home market of China.
Eupraxia Pharmaceuticals (NASDAQ:EPRX) has secured a long-term financial runway, shifting focus toward pivotal data readouts for its lead gastrointestinal program following a successful fourth quarter and a transformative February financing.
Pony.ai (NYSE:PONY) took a significant step toward the mass-market commercialization of autonomous driving on March 13, 2026, by integrating its driverless robotaxi service directly into the Tencent Mobility Service via WeChat.
Greenfire Resources (NYSE:GFR) achieved a major financial de-leveraging milestone in 2025, moving to a debt-free position while delivering production results that surpassed its annual targets.
Kyivstar Group (NASDAQ:KYIV), the first Ukrainian company to list on the Nasdaq, delivered a robust performance for fiscal year 2025, signaling that its evolution into a diversified digital operator is successfully offsetting the challenges of a volatile operating environment.
VEON (NASDAQ:VEON) reported a record-breaking finish to 2025, with fourth-quarter results significantly exceeding market expectations on the back of rapid expansion into digital financial services and entertainment.
HIVE Digital Technologies (NASDAQ:HIVE) and AMC Robotics (NASDAQ:AMCI) have entered a strategic partnership to bridge the gap between heavy-duty robotics and high-performance cloud computing.
Precision BioSciences (NASDAQ:DTIL) reported a sharp swing to profitability in its final quarter of 2025, a result primarily driven by the recognition of deferred revenue from its heavyweight partnerships in the genome-editing space.
G-III Apparel Group (NASDAQ:GIII) on Wednesday reported fiscal 2026 net sales of $2.96 billion for the period ended January 31, 2026, a decrease of 7% from the prior year, reflecting softer wholesale demand in certain categories and ongoing challenges in the retail apparel environment.
Gyre Therapeutics (NASDAQ:GYRE) reported a year of strategic transformation and steady financial growth for the full year 2025, posting total revenue of $116.6 million, a 10.2% increase compared to the prior year.
Resolute Holdings Management (NYSE:RHLD) reported a net loss for its first full fiscal year as a standalone public company, a period marked by its strategic separation from GPGI and the foundational build-out of its asset management platform.
Rapid Micro Biosystems (NASDAQ:RPID) delivered a record-breaking performance in the final quarter of 2025, signaling a tipping point in the adoption of its automated quality control technology by the world's largest pharmaceutical companies.
GPGI (NYSE:GPGI) delivered a robust performance for the fourth quarter of 2025, characterized by significant margin expansion and the completion of its transition into a multi-industry permanent capital platform.
Saga Communications (NASDAQ:SGA) reported a net loss for the fourth quarter of 2025, primarily driven by a multi-million dollar non-cash impairment charge that wiped out the company's remaining goodwill.
Ballard Power Systems (NASDAQ:BLDP) outperformed Wall Street expectations in the final quarter of 2025, signaling that its focus on heavy-duty transit and stationary power is beginning to gain financial traction.
ProQR Therapeutics (NASDAQ:PRQR), a Leiden, Netherlands-based clinical-stage biotechnology company developing RNA-based therapies for severe genetic rare diseases, on Thursday reported a net loss of $9.1 million for its fourth quarter ended December 31, 2025.
TIC Solutions (NYSE:TIC0 entered a new era in the final quarter of 2025, reporting explosive top-line growth as it integrated the operations of NV5 Global.
Sunbelt Rentals Holdings (NYSE:SUNB) posted modest revenue gains for its fiscal third quarter, reflecting a stabilizing equipment rental market as high interest rates continue to temper the pace of new large-scale construction starts.
Sleep Number (NASDAQ:SNBR) saw its fourth-quarter losses widen substantially, as the specialized mattress maker struggled with a combination of sluggish consumer demand and a heavy non-cash accounting charge.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade